Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.
Leith, C P
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. [electronic resource] - Blood May 1997 - 3323-9 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0006-4971
ATP Binding Cassette Transporter, Subfamily B, Member 1--biosynthesis
Age Factors
Aged
Aged, 80 and over
Antigens, CD--biosynthesis
Antigens, CD34--biosynthesis
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Chromosome Aberrations
Chromosome Disorders
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Double-Blind Method
Drug Resistance, Multiple--genetics
Female
Granulocyte Colony-Stimulating Factor--therapeutic use
Humans
Leukemia, Myeloid, Acute--drug therapy
Leukemia, Promyelocytic, Acute--drug therapy
Male
Middle Aged
Neoplasms, Second Primary--drug therapy
Recombinant Proteins--therapeutic use
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. [electronic resource] - Blood May 1997 - 3323-9 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0006-4971
ATP Binding Cassette Transporter, Subfamily B, Member 1--biosynthesis
Age Factors
Aged
Aged, 80 and over
Antigens, CD--biosynthesis
Antigens, CD34--biosynthesis
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Chromosome Aberrations
Chromosome Disorders
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Double-Blind Method
Drug Resistance, Multiple--genetics
Female
Granulocyte Colony-Stimulating Factor--therapeutic use
Humans
Leukemia, Myeloid, Acute--drug therapy
Leukemia, Promyelocytic, Acute--drug therapy
Male
Middle Aged
Neoplasms, Second Primary--drug therapy
Recombinant Proteins--therapeutic use